Translate this page into:
Thanatophoric dysplasia type I: A lethal neonatal skeletal dysplasia confirmed by FGFR3 mutation analysis
*Corresponding author: Mounika Bazar, Department of Pediatrics, Kasturba Medical College, Mangaluru, Manipal Academy of Higher Education, Manipal, Karnataka, India. bazarmounika@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Bazar M, Poojary S, Shanbhag MM, Moideen F. Thanatophoric dysplasia type I: A lethal neonatal skeletal dysplasia confirmed by FGFR3 mutation analysis. Karnataka Paediatr J. doi: 10.25259/KPJ_54_2025
Abstract
Thanatophoric dysplasia (TD) is a rare and uniformly fatal skeletal dysplasia caused by pathogenic variants in the fibroblast growth factor receptor 3 (FGFR3) gene, with TD type I showing characteristic radiological features and perinatal lethality. We report the case of a 26-year-old G2P1L0D1 mother with hypothyroidism whose foetus was identified on anomaly scan to have features suggestive of skeletal dysplasia. Serial ultrasonography revealed severe polyhydramnios and markedly shortened long bones. At 32+5 weeks of gestation, a male infant was delivered by emergency caesarean section and presented with severe respiratory distress, micromelia, and dysmorphic features. Radiographic evaluation demonstrated classic findings consistent with TD type I. Despite aggressive neonatal resuscitation, the infant succumbed shortly after birth. Singleton exome sequencing identified a heterozygous pathogenic FGFR3 variant (c.746C>G; p.Ser249Cys), while parental testing was negative, confirming a de novo mutation. This case underscores the importance of integrating antenatal imaging with postnatal genetic testing for accurate diagnosis and appropriate genetic counselling. Written informed consent for publication of clinical details and images was obtained from the parents.
Keywords
Fibroblast growth factor receptor 3
Genetic confirmation
Lethal skeletal dysplasia
Neonatal death
Prenatal diagnosis
Skeletal dysplasia
Thanatophoric dysplasia
INTRODUCTION
Thanatophoric dysplasia (TD) is a rare, severe skeletal disorder and the most common form of lethal skeletal dysplasia, with an estimated incidence of 1 in 20,000–50,000 live births.[1] It is caused by activating mutations in the Fibroblast Growth Factor Receptor 3 (FGFR3) gene, located on chromosome 4p16.3, which plays a key role in bone growth and development. FGFR3 acts as a negative regulator of endochondral ossification. Pathogenic gain-of-function mutations – particularly those resulting in aberrant cysteine residues – lead to constitutive receptor activation, impaired chondrocyte proliferation and severe skeletal dysplasia.[2,3] Early prenatal detection and genetic confirmation are essential for prognostication, counselling and planning future pregnancies.[4,5]
TD is classified into two types:[6,7]
Type I: Characterised by curved femurs (‘telephone receiver’ appearance), micromelia, normal skull, narrow thorax and platyspondyly
Type II: Presents with cloverleaf skull (Kleeblattschädel deformity), straight femurs and similar thoracic narrowing.
Antenatal diagnosis is feasible through ultrasonography, with confirmation through molecular genetic testing.[4]The variant c.746C>G (p.Ser249Cys) is the most common pathogenic mutation associated with TD type I.[6]
This case is clinically significant in our regional context, as genetically confirmed cases of TD are rarely reported from South India. To the best of our knowledge, this is among the few cases from the region with definitive FGFR3 variant confirmation, highlighting the value of integrating antenatal imaging with postnatal molecular diagnostics.
CASE REPORT
Maternal and antenatal history
A 26-year-old woman, gravida 2, para 1, living 0, with a prior first-trimester miscarriage and hypothyroidism (on thyroxine supplementation), was referred at 20 weeks’ gestation for an abnormal foetal anomaly scan. The ultrasound revealed features suggestive of skeletal dysplasia, including limb shortening and thoracic narrowing. The anomaly scan was performed at 20 weeks’ gestation, followed by targeted foetal medicine scans at 24 and 28 weeks, which confirmed progressive skeletal abnormalities. A multidisciplinary team comprising obstetricians, foetal medicine specialists and paediatricians counselled the parents regarding the poor prognosis. The couple opted to continue the pregnancy.
Serial antenatal scans showed worsening features, including progressive limb shortening and increasing amniotic fluid index (AFI), with a final AFI measurement of 42 cm.
Delivery and neonatal course
At 32 weeks and 5 days of gestation, an emergency lower-segment caesarean section (LSCS) was performed for polyhydramnios with leaking per vaginum <6 h in the setting of a previous LSCS. A male infant weighing 1.78 kg was delivered. The Apgar scores were 1 and 3 at 1 and 5 min, respectively. The head circumference was 39 cm (>97th centile), and the chest circumference measured 24 cm (severely reduced). Immediate resuscitation included positive-pressure ventilation, endotracheal intubation, chest compressions and administration of adrenaline as per neonatal resuscitation guidelines. The baby was apnoeic at birth, did not cry and required immediate intubation. He was placed on a mechanical ventilator with high settings but showed minimal chest expansion and saturation of peripheral oxygen between 20% and 25%, along with central cyanosis.
Physical examination
The newborn exhibited [Figure 1]:
Macrocephaly with frontal bossing
Potter-like facies
Micromelia involving all four limbs
Bell-shaped thorax
Protuberant abdomen
No spontaneous respiratory effort.

- Clinical photograph of the neonate - clinical phenotype of a neonate with thanatophoric dysplasia type I, exhibiting macrocephaly, depressed nasal bridge, short limbs, redundant skin folds, and a protuberant abdomen, consistent with the characteristic dysmorphic features of the condition.
Radiological findings
Radiographs revealed [Figure 2a and b]:
Platyspondyly
Telephone receiver-shaped femora (severely curved long bones)
Rhizomelic limb shortening
Flaring and squaring of the iliac wings
Hypoplastic scapulae
Narrow thoracic cage with short ribs.

- Baby’s radiograph (a) frontal and (b) lateral view -radiographic features of thanatophoric dysplasia type I showing narrow thorax, short and curved long bones (telephone receiver-shaped femurs), flattened vertebral bodies and macrocephaly with frontal bossing.that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Genetic testing and diagnosis
Singleton exome sequencing was performed using a TWIST capture kit. Sequencing and variant interpretation were performed at a NABL-accredited clinical genetics laboratory using Illumina sequencing technology with >100× mean coverage. The following variant was identified:
Variant not detected in parental samples (confirmed de novo)
Variant reported as pathogenic in ClinVar (ID: 16339)
In silico tools (MutationTaster, M-CAP and REVEL) confirmed pathogenicity.
The findings were consistent with a diagnosis of TD Type I [Table 1].
| Gene | Transcript | Location | Variant | Zygosity | ACMG Classification | Inheritance | Origin |
|---|---|---|---|---|---|---|---|
| FGFR3 | NM_000142.5 | Exon 7 | c. 746C>G (p.Ser249Cys) | Heterozygous | Pathogenic | Autosomal dominant | De novo |
Outcome
Despite all resuscitative measures, the baby had a cardiac arrest approximately 90 min after birth and could not be revived. Genetic counselling was provided to the family. Written informed consent for publication of clinical details and images was obtained from the parents.
DISCUSSION
TD is a uniformly fatal skeletal dysplasia due to its association with pulmonary hypoplasia and thoracic insufficiency.[2] The narrow, bell-shaped thoracic cavity impedes lung development, leading to respiratory failure shortly after birth.[2]
The c.746C>G (p.Ser249Cys) mutation is a recurrent and well-established pathogenic variant found in the majority of TD Type I cases.[6] This mutation results in constitutive activation of FGFR3 signalling, negatively impacting endochondral ossification. The p.Ser249Cys substitution introduces an abnormal cysteine residue, promoting ligand-independent receptor dimerisation and overactivation, which underlies the severe skeletal phenotype observed in TD type I.[3]
Differential diagnoses for severe antenatal limb shortening include achondroplasia, hypochondroplasia and TD type II.[2,8] Achondroplasia typically presents with less severe micromelia, normal thoracic dimensions and characteristic frontal bossing, while TD type II is distinguished by a cloverleaf skull and straight femora. The pronounced femoral curvature, narrow thorax and classic radiographic features in our case strongly supported TD type I. Antenatal detection of severe micromelia, polyhydramnios and a narrow thorax should prompt evaluation for TD. Genetic confirmation is crucial for:
Establishing a definitive diagnosis
Providing accurate recurrence risk information (though most cases are de novo)
Enabling early diagnosis in future pregnancies through targeted testing or preimplantation genetic diagnosis.[4,5]
While traditionally considered lethal, a few long-term survivors of TD with significant medical support have been reported.[9] This brings forth discussions regarding the appropriateness of using ‘lethal’ terminology and the role of palliative versus aggressive care. These cases also reinforce the importance of early, compassionate counselling regarding prognosis, options for pregnancy continuation and postnatal palliative approaches. Ethical considerations include balancing aggressive resuscitation efforts with quality-of-life expectations, parental preferences and cultural context.
CONCLUSION
TD type I remains a devastating diagnosis for families and clinicians. This case emphasises the importance of prenatal suspicion, prompt postnatal evaluation and the role of molecular diagnostics in confirming the condition and guiding genetic counselling. Given the high lethality and recurrence implications, multidisciplinary counselling and planning are essential.
Ethical approval:
The Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate parental consent forms. In the form, the parents have given consent for the patient’s images and other clinical information to be reported in the journal. The parents understand that the patient's names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Thanatophoric dysplasia: Antenatal diagnosis. Med J Armed Forces India. 2009;65:87-8.
- [CrossRef] [PubMed] [Google Scholar]
- Thanatophoric dysplasia In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. Seattle: University of Washington; 1993-2022.
- [Google Scholar]
- FGFR3-related chondrodysplasias: New insights and therapeutic approaches. Hum Mol Genet. 2022;31:R23-36.
- [Google Scholar]
- Prenatal diagnosis of skeletal dysplasia in the era of next-generation sequencing. Prenat Diagn. 2023;43:33-45.
- [Google Scholar]
- Genetic counseling and prenatal diagnosis of thanatophoric dysplasia. Am J Med Genet A. 2008;146A:214-8.
- [Google Scholar]
- Thanatophoric dysplasia (types I and II) caused by distinct mutations in FGFR3. Nat Genet. 1995;9:321-8.
- [CrossRef] [PubMed] [Google Scholar]
- FGFR3-related skeletal dysplasias In: Adam MP, ed. GeneReviews®. Seattle: University of Washington; 1993-2020.
- [Google Scholar]
- Should we stop calling thanatophoric dysplasia a lethal condition? Palliat Med Rep. 2020;1:32-9.
- [CrossRef] [PubMed] [Google Scholar]

